Amylyx Pharmaceuticals (AMLX) R&D US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
R&D, bln rub 11.9 24.6 44.0 93.5 128.2   125.6  
Changes by years, y/y, % +107% +79% +112% +37%     +81.2%

Amylyx Pharmaceuticals. R&D, bln rub

Created with Highcharts 6.0.611.911.924.624.644.044.093.593.5128.2128.2125.6125.620192020202120222023LTM0255075100125150smart-lab.ru

Amylyx Pharmaceuticals. R&D, changes, %

Created with Highcharts 6.0.6106.7106.779.179.1112.2112.237.237.2-2.0-2.02020202120222023LTM-250255075100125smart-lab.ru

Amylyx Pharmaceuticals. R&D, sum by quarters, bln rub

Created with Highcharts 6.0.644.044.022.822.844.944.924.924.930.030.021.221.224.324.329.029.023.123.121.521.524.224.236.336.34 quarter3 quarter2 quarter1 quarter20212022202320240255075100125150smart-lab.ru

Amylyx Pharmaceuticals (AMLX) R&D US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
R&D, bln rub 30.0 44.9 36.3 23.1 21.2   125.6
Changes by years, y/y, % +21% +97% +50% -20% -29%    
Changes by quarters, q/q, % +3% +50% -19% -36% -8%    

Amylyx Pharmaceuticals. R&D, bln rub

Created with Highcharts 6.0.644.044.021.521.524.324.324.924.922.822.824.224.229.029.030.030.044.944.936.336.323.123.121.221.22021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q301020304050smart-lab.ru

Amylyx Pharmaceuticals. R&D, changes, y/y, %

Created with Highcharts 6.0.6-48.2-48.212.712.719.719.720.620.696.996.950.050.0-20.3-20.3-29.3-29.32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-75-50-250255075100125smart-lab.ru

Amylyx Pharmaceuticals. R&D, changes, q/q, %

Created with Highcharts 6.0.6-51.3-51.313.013.02.72.7-8.4-8.46.06.020.120.13.43.449.549.5-19.2-19.2-36.2-36.2-8.2-8.22022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-75-50-250255075smart-lab.ru